Prevention of healthcare‐associated Clostridium difficile infection: what works?
- PMID: 20929366
- PMCID: PMC3648222
- DOI: 10.1086/655985
Prevention of healthcare‐associated Clostridium difficile infection: what works?
Abstract
Prevention of Clostridium difficile infection has become extremely important because of increases in its incidence and severity. Unfortunately, efforts at C. difficile infection prevention are hampered by lack of data to support optimal prevention methods, especially for endemic C. difficile infection. Studies are needed to define the optimal prevention practices and to investigate novel prevention methods.
Similar articles
-
Clostridium difficile infection in the intensive care unit.Infect Dis Clin North Am. 2009 Sep;23(3):727-43. doi: 10.1016/j.idc.2009.04.011. Infect Dis Clin North Am. 2009. PMID: 19665092 Free PMC article. Review.
-
Clostridium difficile in the ICU: the struggle continues.Chest. 2011 Dec;140(6):1643-1653. doi: 10.1378/chest.11-0556. Chest. 2011. PMID: 22147824 Free PMC article. Review.
-
Clostridium difficile infection: a new threat on our doorstep.Med J Aust. 2011 Apr 4;194(7):331-2. doi: 10.5694/j.1326-5377.2011.tb02998.x. Med J Aust. 2011. PMID: 21470079 No abstract available.
-
Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence.Am J Gastroenterol. 2010 Nov;105(11):2327-39; quiz 2340. doi: 10.1038/ajg.2010.254. Epub 2010 Jul 6. Am J Gastroenterol. 2010. PMID: 20606676 Review.
-
Fairness of financial penalties to improve control of Clostridium difficile.BMJ. 2008 Nov 20;337:a2097. doi: 10.1136/bmj.a2097. BMJ. 2008. PMID: 19022838 No abstract available.
Cited by
-
Novel metal peroxide nanoboxes restrain Clostridioides difficile infection beyond the bactericidal and sporicidal activity.Bioeng Transl Med. 2023 Sep 5;8(6):e10593. doi: 10.1002/btm2.10593. eCollection 2023 Nov. Bioeng Transl Med. 2023. PMID: 38023694 Free PMC article.
-
Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update.Infect Control Hosp Epidemiol. 2023 Apr;44(4):527-549. doi: 10.1017/ice.2023.18. Infect Control Hosp Epidemiol. 2023. PMID: 37042243 Free PMC article. No abstract available.
-
The Impact of Clostridium Difficile Infections on In-Hospital Outcomes of Venous Thromboembolism (Deep Vein Thrombosis or Pulmonary Embolism) Hospitalizations.Cureus. 2020 Jul 15;12(7):e9195. doi: 10.7759/cureus.9195. Cureus. 2020. PMID: 32685328 Free PMC article.
-
Fecal calprotectin concentrations in cancer patients with Clostridium difficile infection.Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2341-2346. doi: 10.1007/s10096-018-3381-9. Epub 2018 Sep 21. Eur J Clin Microbiol Infect Dis. 2018. PMID: 30242543 Free PMC article.
-
Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.Clin Infect Dis. 2018 Apr 3;66(8):1192-1203. doi: 10.1093/cid/cix962. Clin Infect Dis. 2018. PMID: 29112710 Free PMC article.
References
-
- Dubberke ER, Gerding DN, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(Suppl 1):S81–S92. - PubMed
-
- Johnson S, Gerding DN, Olson MM, Weiler MD, Hughes RA, Clabots CR, et al. Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med. 1990;88(2):137–140. - PubMed
-
- Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother. 2007;59(5):990–995. - PubMed
-
- Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med. 1994;120(4):272–277. - PubMed
-
- Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45(Suppl 2):S112–S121. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical